IMNM
Price
$6.71
Change
+$0.45 (+7.19%)
Updated
Apr 2 closing price
Capitalization
583.44M
35 days until earnings call
LRMR
Price
$2.20
Change
+$0.20 (+10.00%)
Updated
Apr 2 closing price
Capitalization
140.86M
35 days until earnings call
Ad is loading...

IMNM vs LRMR

Header iconIMNM vs LRMR Comparison
Open Charts IMNM vs LRMRBanner chart's image
Immunome
Price$6.71
Change+$0.45 (+7.19%)
Volume$1.29M
Capitalization583.44M
Larimar Therapeutics
Price$2.20
Change+$0.20 (+10.00%)
Volume$1.63M
Capitalization140.86M
IMNM vs LRMR Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. LRMR commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a StrongBuy and LRMR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IMNM: $6.71 vs. LRMR: $2.20)
Brand notoriety: IMNM and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 107% vs. LRMR: 214%
Market capitalization -- IMNM: $583.44M vs. LRMR: $140.86M
IMNM [@Biotechnology] is valued at $583.44M. LRMR’s [@Biotechnology] market capitalization is $140.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMNM and LRMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 4 bearish.
  • LRMR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -5.36% price change this week, while LRMR (@Biotechnology) price change was -2.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

IMNM is expected to report earnings on May 08, 2025.

LRMR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($583M) has a higher market cap than LRMR($141M). IMNM YTD gains are higher at: -36.817 vs. LRMR (-43.152). LRMR has higher annual earnings (EBITDA): -73.44M vs. IMNM (-109.95M). IMNM has more cash in the bank: 240M vs. LRMR (204M). IMNM has less debt than LRMR: IMNM (2.72M) vs LRMR (5.36M). IMNM has higher revenues than LRMR: IMNM (10.1M) vs LRMR (0).
IMNMLRMRIMNM / LRMR
Capitalization583M141M413%
EBITDA-109.95M-73.44M150%
Gain YTD-36.817-43.15285%
P/E RatioN/AN/A-
Revenue10.1M0-
Total Cash240M204M118%
Total Debt2.72M5.36M51%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMLRMR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 29 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDSX32.690.49
+1.52%
Artisan Small Cap Advisor
CMRAX9.910.02
+0.20%
Calamos Merger Arbitrage A
AFCMX16.77N/A
N/A
American Century Focused Intl Gr R6
HFMCX22.99N/A
N/A
Hartford MidCap A
LIRSX8.65N/A
N/A
Lord Abbett International Value R4

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+7.19%
KYMR - IMNM
51%
Loosely correlated
+4.46%
BEAM - IMNM
49%
Loosely correlated
+4.79%
IDYA - IMNM
49%
Loosely correlated
+10.70%
RXRX - IMNM
48%
Loosely correlated
+3.83%
SYRE - IMNM
47%
Loosely correlated
+1.27%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+10.00%
SVRA - LRMR
45%
Loosely correlated
+5.24%
ACLX - LRMR
42%
Loosely correlated
+10.76%
IMNM - LRMR
41%
Loosely correlated
+7.19%
ERAS - LRMR
41%
Loosely correlated
+4.56%
OLMA - LRMR
40%
Loosely correlated
-0.30%
More